Related references
Note: Only part of the references are listed.Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives
A. Milani et al.
ANNALS OF ONCOLOGY (2013)
In silico Design of Discontinuous Peptides Representative of B and T-cell Epitopes from HER2-ECD as Potential Novel Cancer Peptide Vaccines
Mahdavi Manijeh et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Linear and Conformational B Cell Epitope Prediction of the HER 2 ECD-Subdomain III by in silico Methods
Manijeh Mahdavi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles
Seyed Amir Jalali et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes
Roopesh Singh Gangwar et al.
VIRUS RESEARCH (2012)
Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature
Wen Zhang et al.
BMC BIOINFORMATICS (2011)
Anti-HER2 vaccines: The HER2 immunotargeting future?
M. Z. Ladjemi et al.
PATHOLOGIE BIOLOGIE (2011)
Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42
Trine Veje Axelsen et al.
VACCINE (2011)
Immunization with synthetic VEGF peptides in ovarian cancer
Bing Wang et al.
GYNECOLOGIC ONCOLOGY (2010)
Anti-HER-2 engineering antibody ChA21 inhibits growth and induces apoptosis of SK-OV-3 cells
AnLi Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Sequential Immunization with Heterologous Chimeric Flaviviruses Induces Broad-Spectrum Cross-Reactive CD8+ T Cell Responses
Rekha Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Structure-Activity Relationships in Peptide-Antibody Complexes: Implications for Epitope Prediction and Development of Synthetic Peptide Vaccines
Shu-wen W. Chen et al.
CURRENT MEDICINAL CHEMISTRY (2009)
MAP dendrimer elicits antibodies for detecting rat and mouse GH-binding proteins
Roberto M. Aguilar et al.
JOURNAL OF PEPTIDE SCIENCE (2009)
PEP-FOLD: an online resource for de novo peptide structure prediction
Julien Maupetit et al.
NUCLEIC ACIDS RESEARCH (2009)
Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic peptide from the E1 region of the hepatitis C virus
Ashraf A. Tabll et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2008)
Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities
NK Dakappagari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural analysis of the epitopes on erbB2 interacted with inhibitory or non-inhibitory monoclonal antibodies
JN Wang et al.
MOLECULAR IMMUNOLOGY (2004)
Design of synthetic peptidic constructs for the vaccine development against viral infections
I Haro et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2004)
De novo design of peptide Immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies
R Sundaram et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu
J Jasinska et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses
NK Dakappagari et al.
JOURNAL OF IMMUNOLOGY (2003)
Update on HER-2 as a target for cancer therapy - HER2/neu peptides as tumour vaccines for T cell recognition
I Correa et al.
BREAST CANCER RESEARCH (2001)
Share Paper
